The FDA approved GSK antibiotic Blujepa as a treatment for uncomplicated urinary tract infections. The drug's novel mechanism of action addresses a broader range of pathogens and could offer a way to lower the potential for drug resistance.
Balancing healthcare benefits and insurance costs requires research. From becoming a Difference Card member to offering wellness resources, there are many ways to improve healthcare at low cost.
Stephen will be part of the panel, "Here's How We Found Our Healthcare AI Champion".
In this panel a startup founder/CEO will do a 10-minute presentation that explains how the startup was able to find a champion within a healthcare organization that led to a successful deployment. This will be followed by a Q&A with the startup presenter and the Champion – either a doctor, provider lead, life sciences lead, payer lead or employer lead.
Finalists in the Pitch Perfect contest at INVEST, scheduled for May 20-21 in Chicago at the Willis Tower, span medtech for asthma, diabetic neuropathy, Parkinson's disease, and more. Register today!
While high-acuity options must remain for those that need stronger interventions, millions more could be benefiting from access to low-acuity or minimal interventions.
23andMe filed for bankruptcy on Sunday following years of decreased demand for its genetic testing product. Former users are rushing to delete their data from the company's platform — which is a task that may require some patience.
Innovative sterilization cases and trays are instrumental in reducing infection risk in medical settings. Learn notable things about them and their makers.
The latest episode of Debunked, with MedCity News Editor-in-Chief Arundhati Parmar and Samir Batra, managing partner of Health Innovation Pitch, talked about the many iterations of AI, NIH funding cuts, and a deal to sell Walgreens.
No comments